Countries compete to reform trials in a bid to attract global sponsors

Faced with growing dominance from China, governments are transforming clinical trial frameworks to boost R&D activity. Faced with growing dominance from China, governments are transforming clinical trial frameworks to boost R&D activity. China’s clinical trial initiations have grown in the past decade, whereas Europe’s has stagnated. Credit: VCoscaron/Shutterstock.com. Clinical trial reforms have become abundant across the global pharmaceutical industry as regions look to stake their claim in attracting the next waves of drug research. Amid a surge in research and development (R&D) activity from China – now responsible for one-fifth of pipeline drugs globally – many regions have revitalised clinical…

Source: Clinical Trials Arena